🟢 Immunitybio is trading 4.57% up today with no new company-specific catalyst identified

Immunitybio is trading 4.57% up at $8.23; no new company-specific announcement dated September 2, 2026 was identified.

• The latest listed releases concern August 10 leadership news and August 2026 quarterly results.
• The broader market is mixed, with no major index move exceeding 0.5%, so the gain cannot be confidently attributed to macro sentiment.
• Recent momentum may reflect continued investor interest following strong Anktiva sales and clinical updates, but those catalysts predate September 2.